♦♦ ♦♦ ♦ Objective: It has been proposed that biocompatible bicarbonate/lactate based (Bic/Lac), physiologic-pH peritoneal dialysis (PD) solutions will be beneficial in long-term PD. However, we do not yet have detailed knowledge concerning the comparative physiology of buffer transport for these new solutions and their impact on underlying peritoneal transport of solutes and ultrafiltration (UF). The purpose of this study was to investigate the profile of buffer handling and peritoneal membrane transport characteristics during a single dwell of the new Bic/Lac-based versus standard lactate-based (Lac) PD solution. ♦♦ ♦♦ ♦ Methods: In this prospective crossover study, we compared a 25 mmol/L bicarbonate/15 mmol/L lactate buffered, physiologic pH, low glucose degradation product (GDP) solution (Physioneal; Baxter Healthcare, McGaw Park, Illinois, USA) with a standard lactate buffered, acidic pH, conventional solution (Dianeal; Baxter). 18 patients underwent two peritoneal equilibration tests (PETs) with 2.5% Dianeal and 2.5% Physioneal separated by 1 week. Buffer transport, mass transfer area coefficients (MTACs), solute transport, and UF were determined for the two PETs. All bags were weighed by a nurse before instillation and after drainage to assess the net UF in each dwell. ♦♦ ♦♦ ♦ Results: 18 patients that met the inclusion criteria were enrolled in this study. Whereas intraperitoneal pH remained constant at 7.52 ± 0.11 throughout the dwell with the Bic/ Lac solution, pH was still in the acidic range with the Lac solution after 1 hour (7.29 ± 0.13, p < 0.001); this difference disappeared after the second hour of dwell. The MTACs for creatinine (10.68 ± 3.66 vs 10.73 ± 2.96 mL/minute/ 1.73 m 2 , p > 0.05) and urea (27.94 ± 10.50 vs 27.62 ± 6.95 mL/min/1.73 m 2 , p > 0.05), for Bic/Lac versus Lac respectively, did not differ between these two solutions; transport of glucose and other solutes was also similar. However, after a 4-hour dwell with Bic/Lac solution, net UF was significantly lower than that observed with Lac solution (274.2 ± 223.3 mL vs 366.1 ± 217.3 mL, p = 0.026). ♦♦ ♦♦ ♦ Conclusions: Compared to standard Lac-based solution, Bic/Lac based, pH neutral, low-GDP solution avoids intraperitoneal acidity. Peritoneal mass transport kinetics are similar for small solutes. Net UF is significantly lower with Bic/Lac solution; the mechanism for this is unclear.
tate. The control solution contained 40 mmol/L lactate. The compositions of the two solutions, as reported by the manufacturer, are given in Table 1 .
STUDY POPULATION
Patients eligible to participate in this study met the following criteria: (1) at least 18 years old; (2) on PD; and (3) had signed the informed consent form. Exclusion criteria included (1) acute or chronic exit-site or tunnel infection; (2) an episode of peritonitis in the 2 months prior to the study; and (3) disease serious enough that the investigator rendered the patient not suitable for the trial.
Our institution's Independent Ethics Committee/ Institutional Review Board gave written approval for the study.
STUDY PROCEDURES
After giving informed consent, patients presented themselves to the clinic for two visits that were separated by 1 week. The PD prescription was kept constant during the study period. The overnight dwell solutions preceding the study day did not include a 4.25% dextrose solution. Patients on automated PD did not need to be on continuous ambulatory PD prior to the study. Patients were given a light standard breakfast approximately 2 hours before the start of the dwell study and received nothing by mouth for the 4 hours of the dwell. An indwelling catheter was inserted in a peripheral vein for blood sampling. A PET was performed using the procedure proposed by Twardowski (13) : With the patient sitting, the previous dwell was drained over 20 minutes, then, with the patient supine, 2.0 L 2.5% Lac solution (or products (GDPs) in the solution. It has been shown that new low-GDP PD solutions improve peritoneal cellular function (3) (4) (5) (6) .
Although bicarbonate has been considered the desirable buffer for PD, studies suggest that a solution based on a mixture of bicarbonate and lactate (Bic/Lac) may be more biocompatible than one comprised of bicarbonate alone (7, 8) . In addition, the Bic/Lac solution appears to be more effective than pure bicarbonate solution at correcting infusion pain in PD patients (9) . Hence, a combination of 25 mmol/L bicarbonate plus 10 or 15 mmol/L lactate was proposed (1, 10) . The bicarbonate concentration of this balanced formulation was selected because it is the physiologic plasma level; the supplemented lactate helps maintain acid-base balance. The pCO 2 in this formulation is at the physiologic level, as is its pH. Clinical benefits of this Bic/Lac solution have been reported (11, 12) ; however, the comparative physiology of buffer transport for these solutions and their impact on underlying peritoneal transport remain to be elucidated in detail. Further, whether buffer systems have an effect on solute transport and ultrafiltration (UF) has not been fully examined.
This study was done to investigate the temporal profile of buffer handling and peritoneal membrane transport characteristics during a single dwell of either Bic/ Lac-or lactate-based (Lac) PD solution.
METHODS

STUDY DESIGN
This prospective controlled study with a crossover design compared a Bic/Lac buffered, physiologic pH, low-GDP solution (Physioneal; Baxter Healthcare, McGaw Park, Illinois, USA) with a standard Lac buffered, acidic pH, conventional solution (Dianeal; Baxter). Each patient was asked to sign an informed consent form. Patients underwent two single-dwell evaluations: in one, a peritoneal equilibration test (PET)-like evaluation was done using 2.5% Lac solution and in the other, a PET-like evaluation with 2.5% Bic/Lac solution was performed. The order of performance of the two tests was random. The primary efficacy variable was the metabolic response (lactate and bicarbonate transport) to the single dwell with either solution. Secondary measurements included solute removal and UF as well as mineral balance.
STUDY SOLUTIONS
The study solution, provided in two-chambered bags, contained 25 mmol/L bicarbonate and 15 mmol/L lac- 2.5% Bic/Lac solution) was infused over 10 minutes. The patient rolled from side to side after each quarter of solution was infused. The time after the infusion was completed was considered the "zero" dwell time. At times 0, 30, 60, 120, and 180 minutes, 200 mL effluent was drained into the effluent bag, which was mixed by inverting 2 -3 times, then a 20 mL sample was withdrawn from the medication port using aseptic technique; the remaining 180 mL of effluent was reinfused to the patient. At 240 minutes, with the patient in the sitting position, effluent was drained over 20 minutes, the bag was mixed by inverting 2 -3 times, and then a 20 mL dialysate sample was withdrawn from the medication port. All bags were weighed by a nurse before instillation and after drainage to assess the UF in each dwell as follows: The full solution bag about to be instilled was weighed before connection to the patient, then, after completion of instillation, the empty solution bag was weighed. The difference between these two weights was recorded as instillation volume. After fully draining the dwelling solution at 4 hours, the full drainage bag was weighed; the empty drainage bag was weighed after dumping the effluent. The difference between these two figures plus 150 mL for sampling volume taken during the study was recorded as drainage volume. Ultrafiltration was calculated as drainage volume minus instillation volume. At baseline, at 120 minutes of dwell time, and at the end of the study, blood samples were withdrawn for desired measurements. Effluent samples were sent for measurements of glucose, urea, creatinine, sodium, phosphate, bicarbonate, lactate, and pH. In addition, the 240-minute sample was tested for uric acid, calcium, total protein, and beta 2-microglobulin. Venous blood samples drawn at 0, 120, and 240 minutes were assayed for glucose, urea, creatinine, sodium, phosphate, bicarbonate, and lactate. All samples were kept on ice until assayed. Biochemical parameters were examined using standard methods. Creatinine measurements were corrected for the presence of glucose.
Dialysate-over-plasma concentration ratios (D/P) of creatinine, urea, and phosphate, and dialysate glucose at different dwell times over time zero (D/D 0 ) were calculated for the two PETs. Mass transfer area coefficients (MTACs) were calculated according to the Garred model as modified by Krediet et al. (14) :
where V d is volume drained, t is 240 minutes, V i is volume instilled, P is the corresponding mean plasma concentration, D t is the dialysate concentration of the solute after 240 minutes, and BSA is body surface area.
STATISTICAL ANALYSIS
All data are expressed as mean ± SD for normally distributed data, median and range for skewed data, and frequency (%) for categorical data. The intraindividual differences in acid-base status and transport parameters observed between Bic/Lac and Lac PD solutions were evaluated for significance by paired Student's t-test. Pearson's correlation test was used to examine the determinant of buffer transport during the dwell. Statistical analysis was performed using SPSS software, version 13.0 (SPSS Inc., Chicago, Illinois, USA) for Windows operating system (Microsoft Corp., Redmond, Washington, USA). A p value less than 0.05 was considered statistically significant.
RESULTS
DEMOGRAPHICS
The demographics of the 18 studied patients are shown in Table 2 . Their mean age was 57.3 ± 15.8 years; there were 13 males and 5 females; median duration on PD was 42.2 (range 3.2 -93.4) months. The underlying renal disease was diabetic nephropathy in 4 (22.2%), chronic glomerulonephritis in 4 (22.2%), hypertensive nephrosclerosis in 2 (11.1%), reflux nephropathy in 2 (11.1%), polycystic kidney disease in 1 (5.6%), amyloidosis in 1 (5.6%), calcineurin toxicity in 1 (5.6%), Wegner's granulomatosis in 1 (5.6%), and unknown causes in 2 (11.1%) patients. Thirteen patients had some residual renal function and 5 were anuric. Four patients were failed transplants. Eight patients had had previous episodes of peritonitis; the peritonitis incidence in the study patients was 1 episode/59.8 patient-months.
BUFFER TRANSPORT
Intraperitoneal pH kinetics remained substantially different for more than 1 hour using the two PD solutions ( Figure 1 ). Whereas intraperitoneal pH remained constant at 7.52 ± 0.11 throughout the 4-hour dwell with the Bic/Lac solution, pH was still in the acidic range with the Lac solution after 1 hour (7.29 ± 0.13, p < 0.001). This difference disappeared after the second hour of dwell. As illustrated in Figure 1 , in a single dwell with Lac solution, dialysate bicarbonate concentration progressively increased so that, by 4 hours, it approached that of blood. Conversely, dialysate bicarbonate remained stable throughout the dwell with Bic/Lac solution. Dialysate lactate concentration decreased progressively during the dwell of both PD solutions. No changes in blood bicarbonate or lactate levels between single dwells of Bic/Lac and Lac solutions occurred (Table 3) .
At the end of the dwell, the dialysate bicarbonate concentration in the Bic/Lac solution correlated only with the levels of blood bicarbonate at the beginning of the dwell (r = 0.781, p < 0.001; Figure 2 ). With Lac solution, the final dialysate bicarbonate correlated with peritoneal transport characteristics (r = 0.722, p < 0.01 with creatinine D/P ratio at 240 minutes, Figure 3 ; r = 0.641, p < 0.01 with urea D/P ratio at 240 minutes; r = -0.675, p < 0.01 with glucose D/D 0 ratio), but did not correlate with blood bicarbonate levels. (Table 5) .
ULTRAFILTRATION
Net UF after 4 hours of dwell with Bic/Lac solution was 274.2 ± 223.3 mL, which was significantly lower than that observed with Lac solution (366.1 ± 217.3 mL); the mean difference was 91.9 mL (p = 0.026) ( Table 4) .
DISCUSSION
A limited number of studies have evaluated the kinetics of buffer transport in PD; the findings reflect the particular buffer system used. In our study, both with conventional Lac-buffered solutions and with solutions containing Bic/Lac composite buffer systems, we found no changes in blood acid-base parameters during a single dwell in patients under steady state conditions. However, the dialysate acid-base parameters were significantly different. Since Lac-buffered solutions are, by definition, devoid of bicarbonate, the latter will diffuse from the blood side to the dialysate down its concentration gradient, resulting in a loss of blood bicarbonate. Our results show that the final dialysate bicarbonate in Lac-buffered solutions correlated with the peritoneal transport characteristics. This implies that bicarbonate loss is determined by peritoneal transport permeability. Hernandez-Jaras et al. (15) also found that bicarbonate loss was higher in high and high-average transporters than in low and low-average transporters, during both a single dwell and 24-hour therapy. The progressive rise in bicarbonate in the effluent is associated with a parallel rise in dialysate pCO 2 (16, 17) . The changes in the two components of the Lac-buffered system are reflected in the changes in dialysate pH, which rises rapidly at the beginning of the dwell but does not reach blood pH levels until 120 minutes after instillation into the peritoneal cavity. In the dwell of Bic/Lac-buffered solution, the dialysate concentration of bicarbonate in this solution correlated only with the level of blood bicarbonate. This suggests that bicarbonate transport of Bic/Lac solution is "regulated" by the prevailing level of systemic bicarbonate. The physiologic level of bicarbonate in the Bic/Lac solution anchors the process (17) . Dialysate bicarbonate remained stable throughout the dwell of Bic/Lac, as did dialysate pH, because all these parameters have been formulated at normal physiologic levels. With this mixed buffer system, there is no window of intraperitoneal acidosis and no unregulated transport of bicarbonate.
Although in our study and others (16, 17) , blood acidbase parameters during a single dwell with Lac-buffered and Bic/Lac-buffered solutions were the same, improved correction of acidosis in a chronic setting with bicarbonate-containing PD solution has been reported. In an open, randomized, controlled multicenter study that compared 34 mmol/L Bic-buffered and 35 mmol/L Lacbuffered PD solutions (18) , the authors reported no difference in blood bicarbonate concentration between the two solutions for the population as a whole, but found a significant difference in acidotic patients, who experienced a larger increase from baseline. The use of bicarbonate PD solution instead of Lac-based solution (3) has given significant improvement in acid-base status among children undergoing automated PD. Otte et al. (10) compared the effectiveness of a Lac-buffered solution (35 mmol/L) and a Bic/Lac-buffered solution (25 mmol/L and 10 mmol/L respectively) in restoring normal venous plasma bicarbonate levels. Such levels were seen in 66% of subjects given the Bic/Lac solution and in only 46.2% of the subjects given the Lac-based PD solution.
In the current study, the PETs revealed subtle changes in the transport of creatinine, urea, and glucose at certain time points but the MTACs for these solutes remained the same. The transport of other solutes, including uric acid, calcium, phosphate, total protein, and beta 2-microglobulin, did not differ between these two solutions. This is in keeping with the majority of previous studies (10, 11, 16, (19) (20) (21) (22) .
In the present study we found that the net UF obtained with a single dwell with 25 mmol/L Bic/15 mmol/L Lac solution was significantly lower than that with conventional Lac-buffered solution: the difference was 91.9 mL at 4 hours. Previous studies have reported varied results with respect to UF (summarized in Table 6 ). In accordance with our results, Montenegro et al. (21) , also using a crossover design, performed PETs in 33 adult patients and observed a higher 4-hour net UF using conventional (Stay·Safe; Fresenius Medical Care, Bad Homburg, Germany) versus two new fluids (Bicavera and Balance; Fresenius Medical Care): their difference in UF volume was close to our study (123 mL and 105 mL over 4 hours respectively). Recently, in 36 patients followed up for 1 year (22), the same group again reported higher net UF (both (20) . In both studies (11, 20) , mixed glucose concentrations were used to achieve adequate UF based on the hydration status of each patient and daily UF was assessed by having the patients weigh their own bags. In our study, we used a standard 2.5% glucose concentration and an experienced nurse weighed all the bags before instillation and after drainage to determine net UF in each dwell. In order to examine whether there was a difference in flush-before-fill volume between these two solutionswhich might influence the UF results -we asked the nurse involved in the present study to flush the tubing with 10 bags Lac solution and 10 bags Bic/Lac solution in the same way as was done in the study patients: we found the volume of flush-before-fill was similar with Lac and Bic/Lac solutions (14.2 ± 7.9 mL vs 11.6 ± 5.6 mL, p = 0.398).
We have no explanation for the mechanism of decreased UF with a single dwell of Bic/Lac solution. As mentioned above, solute transport did not change compared to that with Lac-buffered solution, thus the difference in UF likely is not related to vasodilatation and subsequent increase in glucose transport. In the studies by Tranaeus and Simonsen, improved UF with Bic/Lac solution was conceived to be a sign of less initial peritoneal vasodilatation during the dwell (11, 20) . Although, in animal studies (25) , lactate, especially at low pH, seems to act as a primary vasodilator, Mortier et al. (26) recently demonstrated that GDP-containing solutions caused much more vasodilatation of rat mesenteric arterioles than did GDP-free solutions. Lactate-buffered solution, as used in the present study, has an acidic pH with a high concentration of GDPs; therefore, it can induce marked initial vasodilatation. With initial vasodilatation and hence recruitment of capillaries, the "effective" surface area available for filtration increases and this can lead to an increased UF coefficient. Theoretically, during short dwells (2 -3 hours), UF will increase if the vascular surface area is increased because both small solute transport and peritoneal UF coefficient will increase in parallel (27, 28) . However, dissociation between increments in MTAC for small solutes and increments (much lesser) in UF coefficient during vasodilatation will cause a reduced UF (28, 29) . A possible explanation for a reduced UF with Bic/Lac solution, is that bicarbonate has a slightly higher MTAC (20.8 ± 4.8 mL/min) than has lactate (17 -20 mL/min) (29) , and the reflection coefficient for bicarbonate (0.029) is slightly lower than that for lactate (0.032); therefore, when some of the lactate ions are replaced by bicarbonate ions, as in Bic/Lac solution, the osmolarity induced by buffer is decreased and osmotic pressure gradient reduces, causing a reduced UF. On the other hand, it remains unknown whether Bic/Lac solution can reduce water transport by a yet unknown effect on ultrasmallpore aquaporin. Clearly, additional studies are warranted to specifically address the mechanism of the effect of Bic/Lac solution on UF.
Our study has several limitations. Ultrafiltration was not the primary efficacy variable of this study, but the methodology was accurate and we believe our results are accurate. Furthermore, we did not measure the residual volume of the abdominal cavity, which might affect the UF results. However, we used a crossover design and infused and drained in the same way with both Bic/Lac and Lac solutions; therefore it will not have a major impact on our findings. Finally, in the present study, only UF at 4 hours of dwell was investigated; we do not know whether the results of daily UF in a chronic setting will be consistent with our findings.
In conclusion, we have demonstrated that pH neutral, bicarbonate/lactate buffered, low-GDP PD solution can avoid intraperitoneal acidity, which is present for up to 120 minutes with conventional acidic lactate solution. Peritoneal mass transport kinetics are similar for the two solutions that we tested. However, net ultrafiltration was significantly lower during the dwell with Bic/Lac solution. The mechanism for this remains to be determined and needs to be assessed in extended studies.
